ACER - Acer Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACER is currently covered by 1 analysts with an average price target of $3.35. This is a potential upside of $2.45 (272.22%) from yesterday's end of day stock price of $0.9.

Acer Therapeutics's activity chart (see below) currently has 10 price targets and 10 ratings on display. The stock rating distribution of ACER is 100% HOLD.

Stock Analyst Price Targets - Review

Highest price target for ACER is $1, Lowest price target is $1, average price target is $1.5.

Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH MKM on 01-Sep-2023.

Best performing analysts who are covering ACER - Acer Therapeutics:

Laura Chico Constantine Davides Jonathan Aschoff Vernon Bernardino

Currently out of the existing stock ratings of ACER, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1.5

$0.84 (127.27%)

$10

1 years 8 months 8 days ago
(01-Sep-2023)

0/3 (0%)

$0.36 (31.58%)

Buy

$8

$7.34 (1112.12%)

$9

3 years 2 months 2 days ago
(07-Mar-2022)

0/2 (0%)

$5.54 (225.20%)

Buy

$8

$7.34 (1112.12%)

$48

5 years 10 months 14 days ago
(25-Jun-2019)

0/4 (0%)

$3.88 (94.17%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACER (Acer Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ACER (Acer Therapeutics) with a proven track record?

LAURA CHICO

Which analyst has the current lower performing score on ACER (Acer Therapeutics) with a proven track record?

VERNON BERNARDINO

Which analyst has the most public recommendations on ACER (Acer Therapeutics)?

Laura Chico works at WEDBUSH and has 3 price targets and 4 ratings on ACER

Which analyst is the currently most bullish on ACER (Acer Therapeutics)?

Constantine Davides with highest potential upside - $7.34

Which analyst is the currently most reserved on ACER (Acer Therapeutics)?

Vernon Bernardino with lowest potential downside - -$0

Acer Therapeutics in the News

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals

NEWTON, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today announced that Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co. LLC (Glass Lewis) recommended that Acer...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIN, TWNK, PNT, ACER

NEW YORK, Oct. 13, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: P&F Industries, Inc. (NASDAQ: PFIN)’s sale to ShoreView Industries for $13.00 per share. If you are a...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?